Omega-3 (EPA/DHA) and Omega-3 + Antiplatelets: use with caution
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Compound or practice
Omega-3 (EPA/DHA)
Triglyceride-lowering is bankable; everything else scales with your baseline fish intake.
Grade A4 graded outcomesrevised Jun 8, 2026
A hand-written entry in Prometheus's bundled library. Its grades are the entry's own reading of the evidence, not a peer-reviewed review.
Interaction
Omega-3 + Antiplatelets: use with caution
High-dose fish oil adds to antiplatelet bleeding risk.
Grade B0 graded outcomesrevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
No outcome has the same name in both entries. They may still overlap under different wording — read the two lists below.
Graded only in Omega-3 (EPA/DHA)
- Triglycerides Large effectEvidence grade A
- Cardiovascular events (high-risk) Small effectEvidence grade B
- Depression (adjunct, EPA-heavy) Small effectEvidence grade B
- Joint soreness Small effectEvidence grade C
Graded only in Omega-3 + Antiplatelets: use with caution
None — every outcome it grades is graded in both.
Conditions
Only in Omega-3 (EPA/DHA)
- Hypertriglyceridemia ImprovesEvidence grade A
- Depression May improveEvidence grade B
- Rheumatoid arthritis ImprovesEvidence grade B
- Atrial fibrillation May worsenEvidence grade B
Only in Omega-3 + Antiplatelets: use with caution
None.
What each entry says about the other
- Omega-3 + Antiplatelets: use with caution’s entry · Watch with: About Omega-3
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.